Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
What does race have to do with diabetes? Especially in these tumultuous times, we thank advocate Mila Clarke Buckley for her willingness to explore the connection between race, ethnicity, and health disparities for minorities with diabetes.
The scientific contributions emerging biopharma brings to big pharma can’t be understated. Licensing deals – whereby large pharma companies purchase the IP and drug development rights from, typically, a small biotech—are big business. In 2016, the potential total value of strategic alliance payments reached nearly $58 billion. While this figure includes contingent milestone payments and royalties on market revenues, even up-front payments are no drop in the bucket.
The weight loss industry in the United States is vast and generates about $20 billion each year from over 100 million dieters. Commercial weight loss programs design customer-focused program policies to shape and optimize satisfaction and development. These two metrics are tied to how well a program does and the success of the customers in that program. New research in the INFORMS journal Marketing Science finds one key to success is making sure you have the right role model for dieters.
Covid-19 cases are accelerating around the country, reaching new daily highs in states including Texas and Arizona and spurring concerns about prospects for an economic and social revival. Thirty-three states, from Oklahoma to South Carolina and Washington, had a seven-day average of new cases on Tuesday that was higher than their average during the past two weeks, according to a Wall Street Journal analysis of Johns Hopkins University data.
The first wave of the Covid-19 pandemic isn’t even over and U.S. preparations for the second wave are nowhere to be seen. Political leaders like Vice President Michael Pence have said there won’t even be another resurgence, but fresh evidence suggests otherwise: Seven states, including Arizona, Florida and South Carolina, are experiencing new daily cases that more than doubled from two weeks ago. Regardless of whether a second wave is on its way, one thing is clear: The U.S. health care system is still struggling.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine